MedTrace Logo

Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00139269 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2008-06-04

No results posted yet for this study

Summary

The purpose of this study is to determine the appropriate dose, that dose which is found to give maximum effect with limited toxicity, of cisplatin in combination with docetaxel and 5-fluorouracil and then to further define the safety and effectiveness of this combination of medications.

Conditions

  • Advanced Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Head and Neck
  • SSCHN

Interventions

DRUG

Docetaxel

DRUG

Cisplatin

DRUG

5-Fluorouracil

Sponsors & Collaborators

Principal Investigators

  • Marshall Posner, MD · Dana-Farbar Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1998-02-28
Primary Completion
2006-12-31
Completion
2006-12-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00139269 on ClinicalTrials.gov